Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: CRN035
MIFTS: 41

Cranial Nerve Palsy

Categories: Neuronal diseases
Genes Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Cranial Nerve Palsy

About this section

MalaCards integrated aliases for Cranial Nerve Palsy:

Name: Cranial Nerve Palsy 12 15 17
Cranial Nerve Paralysis 12 29
Cranial Nerve Diseases 43 71
Cranial Nerve Palsies 71

Classifications:

MalaCards categories:
Anatomical: Neuronal diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:3817
MeSH 43 D003389
NCIt 49 C26941
SNOMED-CT 67 73013002
UMLS 71 C0010266 C0151311
Sources

Summaries for Cranial Nerve Palsy

About this section
MalaCards based summary : Cranial Nerve Palsy, also known as cranial nerve paralysis, is related to multiple cranial nerve palsy and neurosarcoidosis, and has symptoms including ophthalmoplegia, circumoral paresthesia and neurologic symptoms. An important gene associated with Cranial Nerve Palsy is NT5C3A (5'-Nucleotidase, Cytosolic IIIA). The drugs leucovorin and Trimethoprim have been mentioned in the context of this disorder. Affiliated tissues include pituitary, brain and bone, and related phenotype is immune system.

Sources

Related Diseases for Cranial Nerve Palsy

About this section

Diseases in the Cranial Nerve Palsy family:

Multiple Cranial Nerve Palsy

Diseases related to Cranial Nerve Palsy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 692)
# Related Disease Score Top Affiliating Genes
1 multiple cranial nerve palsy 34.0 SLC52A3 RHNO1 PRTN3 CRP ACE
2 neurosarcoidosis 33.0 CRP CD4 ACE
3 glossopharyngeal nerve disease 33.0 SLC52A3 RHNO1 CRP ANTXR2
4 abducens nerve disease 33.0 PRL POMC NT5C3A NT5C2 CRP
5 cranial nerve disease 32.9 NT5C3A CRP CD40LG CD4 ANTXR2 ALB
6 brown-vialetto-van laere syndrome 1 32.7 SLC52A3 SLC52A2
7 madras motor neuron disease 32.6 SLC52A3 SLC52A2 SLC52A1
8 herpes zoster 31.1 CRP CD40LG CD4
9 behcet syndrome 31.0 PRTN3 CRP CD40LG CD4 ALB ACE
10 sphenoid sinusitis 30.9 RHNO1 NT5C3A NT5C2
11 asymptomatic neurosyphilis 30.9 CD40LG CD4
12 sarcoidosis 1 30.8 CRP CD40LG CD4 ACE
13 mononeuropathy 30.7 PRTN3 CRP CD40LG
14 mastoiditis 30.7 PRTN3 CRP CD4
15 hypopituitarism 30.6 PRL POMC CRP
16 igg4-related disease 30.5 PRTN3 CRP CD4
17 cavernous sinus thrombosis 30.5 RHNO1 NT5C3A CRP
18 tolosa-hunt syndrome 30.5 PRTN3 NT5C3A CRP ACE
19 granulomatosis with polyangiitis 30.4 PRTN3 CRP CD40LG CD4
20 glossopharyngeal neuralgia 30.4 POMC ANTXR2
21 epidemic typhus 30.4 CRP CD40LG CD4
22 pituitary infarct 30.4 PRL POMC
23 pancytopenia 30.4 CRP CD40LG CD4 ACE
24 bell's palsy 30.4 CD40LG CD4 ANTXR2
25 meningioma, familial 30.3 SYP PRL POMC NT5C3A
26 exophthalmos 30.2 SYP RHNO1 PRTN3 PRL CRP
27 spondyloarthropathy 1 30.2 PRTN3 CRP CD40LG
28 chickenpox 30.2 CRP CD40LG CD4 ALB
29 central retinal artery occlusion 30.1 RHNO1 PRTN3 CRP CD40LG
30 temporal arteritis 30.1 PRTN3 CRP CD40LG CD4
31 thrombophlebitis 30.0 CRP CD40LG ALB
32 leprosy 3 29.9 CD40LG CD4 ALB
33 optic nerve disease 29.8 CRP CD40LG CD4 ALB ACE
34 paranasal sinus disease 29.8 RHNO1 PRTN3 CRP CD40LG CD4
35 meningoencephalitis 29.8 CRP CD40LG CD4 ALB
36 typhoid fever 29.8 CRP CD40LG ALB
37 polyneuropathy 29.7 CRP CD40LG ALB ACE
38 syphilis 29.6 CRP CD40LG CD4 ALB ACE
39 parotitis 29.6 CRP CD40LG CD4 ALB
40 aspiration pneumonia 29.6 CRP CD40LG ALB ACE
41 bone inflammation disease 29.5 PRTN3 CRP CD40LG CD4 ALB
42 vascular disease 29.5 CRP CD40LG CD4 ALB ACE
43 hypokalemia 29.5 POMC ALB ACE
44 end stage renal failure 29.4 PRL CRP ALB ACE
45 migraine with or without aura 1 29.4 PRL POMC CRP CD40LG ALB ACE
46 hypothyroidism 29.2 PRL POMC CRP ALB ACE
47 exanthem 29.1 PRTN3 CRP CD40LG CD4 ALB ACE
48 respiratory failure 29.1 SLC52A3 CRP CD4 ALB ACE
49 facial paralysis 29.0 PRTN3 NT5C3A CRP CD40LG CD4 ANTXR2
50 papilledema 29.0 SYP CRP CD40LG CD4 ALB ACE

Comorbidity relations with Cranial Nerve Palsy via Phenotypic Disease Network (PDN):


Hypertension, Essential

Graphical network of the top 20 diseases related to Cranial Nerve Palsy:



Diseases related to Cranial Nerve Palsy
Sources

Symptoms & Phenotypes for Cranial Nerve Palsy

About this section

UMLS symptoms related to Cranial Nerve Palsy:


ophthalmoplegia, circumoral paresthesia, neurologic symptoms

MGI Mouse Phenotypes related to Cranial Nerve Palsy:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.36 ACE ALB ANTXR2 APC CD4 CD40LG
Sources

Drugs & Therapeutics for Cranial Nerve Palsy

About this section

Drugs for Cranial Nerve Palsy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 108)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
leucovorin Approved Phase 4 58-05-9 6006 143
2
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
3
Sulfamethoxazole Approved Phase 4 723-46-6 5329
4
Sulfadiazine Approved, Investigational, Vet_approved Phase 4 68-35-9 5215
5
Pyrimethamine Approved, Investigational, Vet_approved Phase 4 58-14-0 4993
6
Folic acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
7 Anti-Bacterial Agents Phase 4
8 Folic Acid Antagonists Phase 4
9 Anti-Infective Agents Phase 4
10 Antiparasitic Agents Phase 4
11 Vitamin B Complex Phase 4
12 Antiprotozoal Agents Phase 4
13 Vitamin B9 Phase 4
14 Antimalarials Phase 4
15 Folate Phase 4
16 Trimethoprim, Sulfamethoxazole Drug Combination Phase 4
17
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
18
Cabergoline Approved Phase 3 81409-90-7 54746
19
Methotrexate Approved Phase 3 1959-05-2, 59-05-2 126941
20
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
21
Levoleucovorin Approved, Investigational Phase 3 68538-85-2
22
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
23
Lenograstim Approved, Investigational Phase 3 135968-09-1
24
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
25
Cytarabine Approved, Experimental, Investigational Phase 3 147-94-4, 65-46-3 6253
26
Etoposide Approved Phase 3 33419-42-0 36462
27
Daunorubicin Approved Phase 3 20830-81-3 30323
28
Mercaptopurine Approved Phase 3 50-44-2 667490
29
Prednisone Approved, Vet_approved Phase 3 53-03-2 5865
30
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3 1177-87-3
31
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
32
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
33
Methylprednisolone hemisuccinate Approved Phase 3 2921-57-5
34
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
35 Prednisolone acetate Approved, Vet_approved Phase 3 52-21-1
36
Prednisolone phosphate Approved, Vet_approved Phase 3 302-25-0
37
Hydrocortisone acetate Approved, Vet_approved Phase 3 50-03-3
38
Hydrocortisone Approved, Vet_approved Phase 3 50-23-7 5754
39
Sargramostim Approved, Investigational Phase 3 123774-72-1, 83869-56-1
40
Topotecan Approved, Investigational Phase 3 119413-54-6, 123948-87-8 60700
41
Dactinomycin Approved, Investigational Phase 3 50-76-0 2019 457193
42
Mitoxantrone Approved, Investigational Phase 3 65271-80-9 4212
43
Pegaspargase Approved, Investigational Phase 3 130167-69-0
44
Calcium Approved, Nutraceutical Phase 3 7440-70-2 271
45
Prednisolone hemisuccinate Experimental Phase 3 2920-86-7
46 Protective Agents Phase 3
47 Neurotransmitter Agents Phase 3
48 Dopamine Agents Phase 3
49 Dopamine agonists Phase 3
50 Antiparkinson Agents Phase 3

Interventional clinical trials:

(show all 25)
# Name Status NCT ID Phase Drugs
1 Pyrimethamine Plus Sulfadiazine Versus Trimethoprim Plus Sulfamethoxazole for Treatment of Toxoplasmic Encephalitis in AIDS Patients: A Randomized Controlled Trial. Completed NCT00367081 Phase 4 TMX-SMX (Bactrim(R));Pyrimethamine plus Sulfadiazine plus leucoverin
2 Dopamine Agonist Cabergoline in Residual Clinically Nonfunctioning Pituitary Adenoma After Transphenoidal Surgery: A Single Center, Open Label and Randomized Clinical Trial Completed NCT03271918 Phase 3 Cabergoline
3 Randomized Study of Vincristine, Actinomycin-D, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine, Topotecan and Cyclophosphamide for Patients With Intermediate Risk Rhabdomyosarcoma Completed NCT00003958 Phase 3 vincristine sulfate;cyclophosphamide;topotecan hydrochloride
4 A RANDOMIZED PHASE III TRIAL COMPARING DEXAMETHASONE WITH PREDNISONE IN INDUCTION TREATMENT AND BONE MARROW TRANSPLANTATION WITH INTENSIVE MAINTENANCE TREATMENT IN ADOLESCENT AND ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL-4) Completed NCT00002700 Phase 3 asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;doxorubicin hydrochloride;leucovorin calcium;mercaptopurine;methotrexate;mitoxantrone hydrochloride;prednisolone;prednisone;therapeutic hydrocortisone;vincristine sulfate
5 FAB LMB 96 -- Treatment of Mature B-CELL Lymphoma/Leukemia: A SFOP LMB 96/CCG 5961/UKCCSG NHL 9600 Cooperative Study Completed NCT00002757 Phase 3 cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;methotrexate;prednisolone;prednisone;therapeutic hydrocortisone;vincristine sulfate
6 Treatment of Acute Lymphoblastic Leukemia in Children Completed NCT00400946 Phase 3 asparaginase;cyclophosphamide;cytarabine;dexamethasone;dexrazoxane hydrochloride;doxorubicin hydrochloride;etoposide;leucovorin calcium;mercaptopurine;methotrexate;methylprednisolone;pegaspargase;prednisolone;therapeutic hydrocortisone;vincristine sulfate
7 A Multi-Center, Randomized Controlled Study Trial to Investigate the Effect of Varying Volumes of Blood Patch on the Resolution of Postdural Puncture Headache (PDPH) Terminated NCT00373074 Phase 2, Phase 3
8 A Clinicopathological Study In Burkitts's And Burkitt-Like Non-Hodgkin's Lymphoma Completed NCT00040690 Phase 2 cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;ifosfamide;leucovorin calcium;methotrexate;vincristine sulfate
9 PILOT MULTINATIONAL PROTOCOLS IN ACUTE LYMPHOBLASTIC LEUKEMIA AND DIFFUSE NON-HODGKIN'S LYMPHOMA Completed NCT00018954 Phase 2 asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;doxorubicin hydrochloride;etoposide;ifosfamide;mercaptopurine;methotrexate;prednisone;vincristine sulfate
10 TREATMENT OF ISOLATED CNS RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA -- A PEDIATRIC ONCOLOGY GROUP-WIDE PHASE II STUDY Completed NCT00002704 Phase 2 asparaginase;cyclophosphamide;daunorubicin hydrochloride;dexamethasone;etoposide;leucovorin calcium;liposomal cytarabine;mercaptopurine;mesna;methotrexate;therapeutic hydrocortisone;thiotepa;vincristine sulfate
11 Stop LCNP: High Dose Steroid Therapy for Late Radiation-Associated Lower Cranial Neuropathy: A Phase I/II Dose Finding Trial Recruiting NCT04151082 Phase 1, Phase 2 Methylprednisolone;Prednisone
12 The Feasibility of Steady State CBV Mapping Using Ferumoxytol Immediately After Gadolinium Enhanced MRI of the CNS Recruiting NCT03270059 Phase 2 Ferumoxytol;Gadolinium
13 Teeth and Jaw Misalignment in Patients Suffering From Congenital Fourth Cranial Nerve Palsy Unknown status NCT02149355
14 Correlation Between Cerebral Microembolisation and Plaque Characteristics After Carotid Revascularization Unknown status NCT03303430
15 Inferior Alveolar Nerve Injury After Bilateral Sagittal Split Osteotomy in Oral Clefts Unknown status NCT01875965
16 Strabismus Measurements Using Automated 3D Video Oculography Completed NCT02228070
17 Predictive Factors of Re-craniotomy and Major Non-neurological Complications in Elective Neurosurgery: A Prospective Cohort Study Completed NCT03910556 Propofol
18 Phase IV Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis Completed NCT01284127
19 Treatment for Newly Diagnosed Patients With Stage III/IV Non-Hodgkin Lymphoma-Study XIII (A Therapeutic Pilot Study) Completed NCT00187122 Vincristine;Daunomycin;L-Asparaginase;Cytarabine;Methotrexate;Mercaptopurine;Etoposide;Cyclophosphamide;Prednisone;Dexamethasone
20 Incidence of Post-Dural Puncture Headache Following Unintentional Dural Puncture: A Randomized Trial of Intrathecal Morphine Versus Saline Completed NCT01977898 Morphine;Saline
21 Diffusion Tensor Imaging and Tractography for Cranial Nerves. Interest in Skull Base Surgery and Anatomy Recruiting NCT02978911
22 Routine Care Study Evaluating Ocular Torsion Recruiting NCT02894411
23 Does Light and Noise Isolation Change the Melatonin Levels and Inflammatory Response After Cranial Surgery in an Intensive Care Unit Recruiting NCT03659760
24 Neurovirus Emerging in the Americas Study (NEAS): Neurologic Manifestations of the Arbovirus Dengue, Chikungunya and Zika Infections in Colombia Recruiting NCT03206541
25 CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap Withdrawn NCT01932255

Search NIH Clinical Center for Cranial Nerve Palsy

Cochrane evidence based reviews: cranial nerve diseases

Sources

Genetic Tests for Cranial Nerve Palsy

About this section

Genetic tests related to Cranial Nerve Palsy:

# Genetic test Affiliating Genes
1 Cranial Nerve Paralysis 29
Sources

Anatomical Context for Cranial Nerve Palsy

About this section

MalaCards organs/tissues related to Cranial Nerve Palsy:

40
Pituitary, Brain, Bone, Lung, Tongue, Prostate, Myeloid
Sources

Publications for Cranial Nerve Palsy

About this section

Articles related to Cranial Nerve Palsy:

(show top 50) (show all 1657)
# Title Authors PMID Year
1
Association of Anatomical Site and Clinical Outcome in Intracerebral Hemorrhage Patients with or without Intraventricular Extension. 61
32009363 2020
2
Enlargement of a Middle Cerebral Artery Aneurysm after Intra-Aneurysmal Embolization with Parent Artery Preservation for an Ipsilateral Large Internal Carotid Artery Aneurysm: A Case Report. 61
31822375 2020
3
Rathke's cleft cyst presenting as incomplete cavernous sinus syndrome and disc edema: a case report with literature review. 61
31493011 2020
4
Ophthalmic manifestations of arbovirus infections in adults. 61
31679764 2020
5
[Use of the Multidisciplinary Specialised Case Conference at the Freiburg Orbital Centre]. 61
32016941 2020
6
Clinical Outcomes of Infratentorial Meningiomas Surgery in a Developing Country. 61
32032796 2020
7
Primary epithelial-myoepithelial carcinoma of the pituitary gland. 61
31900996 2020
8
Incidence and prognostic role of the ocular manifestations of neuroblastoma in children. 61
32006485 2020
9
Comparative Analysis Using Propensity Score Matching Analysis: Primary Closure versus Patch Angioplasty During Carotid Endarterectomy. 61
30763710 2020
10
Clinical outcomes and aetiology of fourth cranial nerve palsy with acute vertical diplopia in adults. 61
31932705 2020
11
Acquired Ocular Motor Palsy: Current Demographic and Etiological Profile. 61
31977330 2020
12
Acquired Ocular Motor Palsy: Current Demographic and Etiological Profile. 61
31990742 2020
13
Impact of transvenous embolization via superior ophthalmic vein on reducing the total number of coils used for patients with cavernous sinus dural arteriovenous fistula. 61
31872315 2019
14
The incidence and etiology of sixth cranial nerve palsy in Koreans: A 10-year nationwide cohort study. 61
31804597 2019
15
Cause of acquired onset of diplopia due to isolated third, fourth, and sixth cranial nerve palsies in patients aged 20 to 50 years in Korea: A high resolution magnetic resonance imaging study. 61
31669731 2019
16
Herpes simplex virus type 2 meningitis as a manifestation of Good's syndrome. 61
31858482 2019
17
Spontaneous Perforation of Anterior Choroidal Artery with Resultant Pseudoaneurysm Formation: Unusual Cause of Subarachnoid Hemorrhage. 61
31698118 2019
18
Commentary: Anatomic and Thermometric Analysis of Cranial Nerve Palsy After Laser Amygdalohippocampotomy for Mesial Temporal Lobe Epilepsy. 61
31768557 2019
19
Newly occurring cranial nerve palsy after endovascular treatment of cavernous sinus dural arteriovenous fistulas. 61
31048455 2019
20
A Comparative Study Between Traditional Microscopic Surgeries and Endoscopic Endonasal Surgery for Skull Base Chordomas. 61
31785435 2019
21
Implication of the inferolateral trunk of the cavernous internal CAROTID artery in cranial nerve blood supply: Anatomical study and review of the literature. 61
31330308 2019
22
Strategy and Technique of Endonasal Endoscopic Bony Decompression and Selective Tumor Removal in Symptomatic Skull Base Meningiomas of the Cavernous Sinus and Meckel's Cave. 61
31226453 2019
23
Sixteen-and-a-half syndrome with metastatic pons tumor: A case report. 61
31764815 2019
24
Case of non-alcoholic Wernicke's encephalopathy. 61
31732541 2019
25
Sensorineural Deafness After Spine Surgery: Case Series and Literature Review. 61
31382067 2019
26
Predictors of hospital discharge outcome from the presenting clinical characteristics and the first cerebrospinal fluid analysis among the patients with cryptococcal meningitis. 61
31590063 2019
27
Anatomical similarity between the Sost-knockout mouse and sclerosteosis in humans. 61
31729194 2019
28
[Advantages and Disadvantages of Carotid Endarterectomy and Carotid Artery Stenting:Notes from a Hybrid Neurosurgeon]. 61
31761776 2019
29
Extended Survival After Surgical Resection for Pituitary Metastases: Clinical Features, Management, and Outcomes of Metastatic Disease to the Sella. 61
31784491 2019
30
Delayed onset vagus nerve paralysis after occipital condyle fracture in a horse. 61
31556150 2019
31
Surgical and Functional Outcome after Resection of 57 Tentorial Meningiomas. 61
31601939 2019
32
Cranial nerve palsy: an unusual presentation of a fulminant fungal disease. 61
31305937 2019
33
Nishida procedure associated with botulinum toxin in a long-standing complete bilateral sixth cranial nerve palsy. 61
31326157 2019
34
Approach to Diplopia. 61
31584541 2019
35
Isolated Trochlear Nerve Palsy in a Patient with Superior Cerebellar Rete Mirabile. 61
31181360 2019
36
Pituitary Apoplexy: Results of Surgical and Conservative Management Clinical Series and Review of the Literature. 61
31302273 2019
37
Sixth Cranial Nerve Palsy and Vertigo Caused by Vertebrobasilar Insufficiency. 61
31591859 2019
38
Invasive Fungal Carotiditis: A Rare Manifestation of Cranial Invasive Fungal Disease: Case Series and Systematic Review of the Literature. 61
31660355 2019
39
Sixth cranial nerve palsy and ipsilateral segmental carotid arteritis after tooth alveolectomy. 61
30982133 2019
40
Making Microguidewire Loop Facilitates Navigation Through Tortuous or Abruptly Angulated Head and Neck Veins to Access Cavernous Sinus Dural Arteriovenous Fistulas. 61
31158531 2019
41
Relationship of clinical presentation and angiographic findings in patients with indirect cavernous carotid fistulae. 61
30777891 2019
42
Skull base osteomyelitis: factors implicating clinical outcome. 61
30840222 2019
43
Clinical characteristics of tuberculous meningitis combined with cranial nerve palsy. 61
31336359 2019
44
Anatomic and Thermometric Analysis of Cranial Nerve Palsy after Laser Amygdalohippocampotomy for Mesial Temporal Lobe Epilepsy. 61
31555820 2019
45
Disseminated lymphoblastic lymphoma revealed by an isolated third cranial nerve palsy. 61
31476885 2019
46
Spontaneous Persistent Primitive Trigeminal Artery-Cavernous Sinus Fistula Successfully Treated by Multipronged Coil Embolization: Case Report and Literature Review. 61
31078800 2019
47
Suprasellar Epidermoid Cyst: Case Report of Extended Endoscopic Transsphenoidal Resection and Systematic Review of the Literature. 61
31121364 2019
48
Recurrent and Progressive Facial Baroparesis on Flying Relieved by Eustachian Tube Dilation. 61
30895801 2019
49
Adjuvant Radiation Therapy Compared with Observation Alone for Postoperative Residual Nonfunctional Pituitary Adenomas. 61
31103758 2019
50
Diffuse midline glioma with an H3 K27M mutation: A comparison integrating the clinical, radiological, molecular features between adult and pediatric patients. 61
31504810 2019
Sources

Variations for Cranial Nerve Palsy

About this section
Sources

Expression for Cranial Nerve Palsy

About this section
Search GEO for disease gene expression data for Cranial Nerve Palsy.
Sources

Pathways for Cranial Nerve Palsy

About this section
Sources

GO Terms for Cranial Nerve Palsy

About this section

Biological processes related to Cranial Nerve Palsy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 adenosine metabolic process GO:0046085 9.16 NT5C3A NT5C2
2 riboflavin metabolic process GO:0006771 9.13 SLC52A3 SLC52A2 SLC52A1
3 riboflavin transport GO:0032218 8.8 SLC52A3 SLC52A2 SLC52A1

Molecular functions related to Cranial Nerve Palsy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 virus receptor activity GO:0001618 9.13 SLC52A2 SLC52A1 CD4
2 riboflavin transmembrane transporter activity GO:0032217 8.8 SLC52A3 SLC52A2 SLC52A1
Sources

Sources for Cranial Nerve Palsy

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....